Page last updated: 2024-10-30

mebendazole and Pancreatic Neoplasms

mebendazole has been researched along with Pancreatic Neoplasms in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Limbu, KR	2
Chhetri, RB	2
Oh, YS	2
Baek, DJ	2
Park, EY	2

Other Studies

1 other study available for mebendazole and Pancreatic Neoplasms

Article	Year
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022
Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Molecules (Basel, Switzerland), 2022, Nov-22, Volume: 27, Issue:23 Topics: Cell Proliferation; Humans; Lysophospholipids; Mebendazole; Pancreatic Neoplasms; Phosphotransferase	2022